XKRX:323990 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
19050.00
(+10.5%)
May 20
Business Description
Vaxcell-Bio Therapeutics
ISIN : KR7323990002
Share Class Description:
XKRX:323990: Ordinary SharesCompare
Compare
Traded in other countries / regions
323990.Korea IPO Date
2020-09-22Description
Vaxcell-Bio Therapeutics is a bio-technology company engaged in the development of Cell-based and Protein-based Immunotherapeutics for the treatment of cancer.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 138.54 | |||||
| Equity-to-Asset | 0.98 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -6.4 | |||||
| 3-Year EPS without NRI Growth Rate | -5.4 | |||||
| 3-Year FCF Growth Rate | -9.9 | |||||
| 3-Year Book Growth Rate | 1.5 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 90.19 | |||||
| 9-Day RSI | 79.02 | |||||
| 14-Day RSI | 67.98 | |||||
| 6-1 Month Momentum % | -20.9 | |||||
| 12-1 Month Momentum % | -44.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 55.43 | |||||
| Quick Ratio | 55.33 | |||||
| Cash Ratio | 54.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -32 | |||||
| Shareholder Yield % | -0.05 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -36120.78 | |||||
| ROE % | -31.59 | |||||
| ROA % | -30.44 | |||||
| ROIC % | -112.83 | |||||
| ROC (Joel Greenblatt) % | -379.14 | |||||
| ROCE % | -30.81 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 27214.28 | |||||
| PB Ratio | 5.24 | |||||
| Price-to-Tangible-Book | 5.25 | |||||
| EV-to-EBIT | -37.9 | |||||
| EV-to-EBITDA | -39.45 | |||||
| EV-to-Revenue | 28258.37 | |||||
| EV-to-FCF | -35.98 | |||||
| Price-to-Net-Current-Asset-Value | 8.8 | |||||
| Price-to-Net-Cash | 9.01 | |||||
| Earnings Yield (Greenblatt) % | -2.64 | |||||
| FCF Yield % | -2.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vaxcell-Bio Therapeutics Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 26.637 | ||
| EPS (TTM) (â‚©) | -495.113 | ||
| Beta | 1.78 | ||
| Volatility % | 51.47 | ||
| 14-Day RSI | 67.98 | ||
| 14-Day ATR (â‚©) | 780.939448 | ||
| 20-Day SMA (â‚©) | 16400 | ||
| 12-1 Month Momentum % | -44.62 | ||
| 52-Week Range (â‚©) | 14350 - 42873.685878 | ||
| Shares Outstanding (Mil) | 22.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vaxcell-Bio Therapeutics Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vaxcell-Bio Therapeutics Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vaxcell-Bio Therapeutics Frequently Asked Questions
What is Vaxcell-Bio Therapeutics(XKRX:323990)'s stock price today?
The current price of XKRX:323990 is â‚©19050.00. The 52 week high of XKRX:323990 is â‚©42873.69 and 52 week low is â‚©14350.00.
When is next earnings date of Vaxcell-Bio Therapeutics(XKRX:323990)?
The next earnings date of Vaxcell-Bio Therapeutics(XKRX:323990) is .
Does Vaxcell-Bio Therapeutics(XKRX:323990) pay dividends? If so, how much?
Vaxcell-Bio Therapeutics(XKRX:323990) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers